Medicare Enrolled
Dr. Jayferson Micquel Golepang, M.D.
Internal Medicine · Folsom, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Golepang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Golepang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Golepang
Dr. Jayferson Micquel Golepang is an internal medicine specialist in Folsom, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Golepang performed 4,016 Medicare services across 1,486 unique beneficiaries.
Between the years covered by Open Payments, Dr. Golepang received a total of $4,166 from 38 pharmaceutical and/or device companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Golepang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 7% volume in CA
$4,166 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,016
Medicare services
Top 7% in CA for internal medicine
1,486
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~335 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,440 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
537 | $96 | $200 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
426 | $52 | $88 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
230 | $39 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
156 | $135 | $275 |
| Annual alcohol misuse screening, 5 to 15 minutes | 127 | $20 | $25 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
126 | $138 | $180 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
123 | $84 | $100 |
| Annual depression screening | 113 | $20 | $25 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
104 | $60 | $85 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
81 | $2 | $12 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
59 | $45 | $115 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
54 | $42 | $115 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
53 | $4 | $12 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
48 | $113 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $63 | $170 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
33 | $33 | $35 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
31 | $72 | $80 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
31 | $12 | $55 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
30 | $2 | $25 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
26 | $11 | $110 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $85 | $300 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
21 | $58 | $120 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
18 | $17 | $60 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
16 | $33 | $35 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
15 | $281 | $350 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
13 | $233 | $392 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
12 | $12 | $30 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
11 | $44 | $60 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
11 | $128 | $170 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,166
Total received (2018-2024)
Avg $595/year across 7 years
Top 18% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
234
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,166 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$836
2023
$462
2022
$699
2021
$797
2020
$531
2019
$524
2018
$318
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$127
Novo Nordisk Inc
$95
Janssen Pharmaceuticals, Inc
$72
AstraZeneca Pharmaceuticals LP
$65
ABBVIE INC.
$58
PFIZER INC.
$54
Exact Sciences Corporation
$43
Astellas Pharma US Inc
$42
Amgen Inc.
$38
Novartis Pharmaceuticals Corporation
$37
Lilly USA, LLC
$36
Baxter Healthcare
$30
Medtronic, Inc.
$26
Hologic Sales and Service, LLC
$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Currax Pharmaceuticals LLC
$18
Alexion Pharmaceuticals, Inc.
$17
Philips North America LLC
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Top 3 companies account for 35.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$565
GlaxoSmithKline, LLC.
$519
Novo Nordisk Inc
$437
AstraZeneca Pharmaceuticals LP
$317
Boehringer Ingelheim Pharmaceuticals, Inc.
$300
ABBVIE INC.
$200
Amgen Inc.
$195
Lilly USA, LLC
$147
Janssen Pharmaceuticals, Inc
$145
Radius Health, Inc.
$119
Merck Sharp & Dohme Corporation
$115
Kowa Pharmaceuticals America, Inc.
$112
Amarin Pharma Inc.
$102
Exact Sciences Corporation
$78
Alexion Pharmaceuticals, Inc.
$74
Novartis Pharmaceuticals Corporation
$61
AbbVie Inc.
$59
Hologic, LLC
$59
Baxter Healthcare
$57
Alfasigma USA, Inc.
$54
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$51
Esperion Therapeutics, Inc.
$47
Biohaven Pharmaceutical Holding Company Ltd.
$47
Astellas Pharma US Inc
$42
Vanda Pharmaceuticals Inc.
$34
Medtronic, Inc.
$26
Hologic Sales and Service, LLC
$24
ARBOR PHARMACEUTICALS, INC.
$23
SANOFI PASTEUR INC.
$18
Currax Pharmaceuticals LLC
$18
Ironwood Pharmaceuticals, Inc
$18
Philips North America LLC
$17
HOLOGIC INC
$16
SANOFI-AVENTIS U.S. LLC
$16
Boston Scientific Corporation
$14
Silk Road Medical, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Philips Electronics North America Corporation
$12
Top 3 companies account for 36.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ANORO ELLIPTA · APTIMA · AREXVY · Amitiza · BELSOMRA · BREZTRI · BYDUREON · CHANTIX · COLOGUARD · CONTRAVE · CREON · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · HETLIOZ · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · Horizant · INTELLIS ADAPTIVESTIM · JANUVIA · JARDIANCE · LEQVIO · LINZESS · LYRICA · Linzess · Livalo · MOUNJARO · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · RYBELSUS · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · SPRAVATO · STEGLUJAN · STIOLTO RESPIMAT · STRENSIQ · SUPERION · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRULANCE · TRULICITY · ThinPrep · Tymlos · UBRELVY · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,172
Per 100K population
74.0
County median income
$88,724
Nearest hospital
MERCY HOSPITAL OF FOLSOM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Golepang is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 18% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Golepang experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Golepang performed 1,440 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Golepang receive payments from pharmaceutical companies?
Yes. Dr. Golepang received a total of $4,166 from 38 companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Golepang's costs compare to other internal medicine physicians in Folsom?
Dr. Golepang's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Golepang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Folsom
Browse internal medicine physicians in Folsom ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology